Watson Rebecca’s Zimmer Biomet ZBH Stock Holding History

Watson Rebecca’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-103	Closed	-$12K	–	361
2020 Q2	$12K	Buy	+103	New	+$11.9K	0.01%	253

Other funds holding ZBH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Watson Rebecca's ZBH Position: Q3 2020 in Review

Watson Rebecca sold out of Zimmer Biomet (ZBH) in Q3 2020, closing a stake of 103 shares — an estimated $12K sold.

Watson Rebecca first reported a position in ZBH in Q2 2020 and held it in 1 quarter. The position peaked at $12K in Q2 2020. 930 funds tracked by Wall St. Rank hold ZBH as of Q3 2020.

Watson Rebecca reported no remaining Zimmer Biomet position as of Q3 2020 after selling out during the quarter.
Watson Rebecca sold 103 Zimmer Biomet shares in Q3 2020, an estimated $12K.
Watson Rebecca first reported a position in Zimmer Biomet in Q2 2020 and held it in 1 quarter.
Watson Rebecca's Zimmer Biomet position peaked at $12K in Q2 2020.
930 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2020.

Based on Watson Rebecca's 13F filing for Q3 2020, filed 22 Oct 2020.